论文部分内容阅读
我们按照华东区再障协作组于1984年制定的康力龙、硝酸一叶秋碱、左旋咪唑联合方案(简称SSL方案)治疗小儿再障17例,疗效较好,现总结如下。1.临床资料:17例均符合1981年廊坊会议再障诊断标准,以SSL方案治疗为主,男11例,女6
We follow the East China District Acellular Sympathetic Group in 1984 formulated by the Kang Lilong, a leucovorin nitrate, levamisole combined program (referred to SSL program) in 17 cases of pediatric aplastic anemia, the effect is better, are summarized as follows. 1. Clinical data: 17 cases are in line with the 1981 Langfang Conference aplastic anemia diagnostic criteria, mainly to the SSL program treatment, 11 males and 6 females